Search

Your search keyword '"Sakamaki, Akira"' showing total 228 results

Search Constraints

Start Over You searched for: Author "Sakamaki, Akira" Remove constraint Author: "Sakamaki, Akira"
228 results on '"Sakamaki, Akira"'

Search Results

7. Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model.

9. Thermoelectric Properties of Antiperovskite Calcium Oxides Ca3PbO and Ca3SnO

13. Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis

17. Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis.

19. Navitoclax improves acute‐on‐chronic liver failure by eliminating senescent cells in mice

20. Cell‐free and concentrated ascites reinfusion therapy versus large‐volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study

21. HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma

22. Effects of Atezolizumab and Bevacizumab on Adrenal Gland Metastasis of Hepatocellular Carcinoma: A Case Report and Review of Literature

25. Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression

26. Effects of a selective PPARα modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model

28. Machine learning prediction model for treatment responders in patients with primary biliary cholangitis.

29. Cumulative risk of developing a new symptom in patients with primary biliary cholangitis and its impact on prognosis

30. Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

31. Involvement of DNA Damage Response via the Ccndbp1–Atm–Chk2 Pathway in Mice with Dextran-Sodium-Sulfate-Induced Colitis

32. Effects of a novel selective PPARα modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model

33. Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study

34. Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function

35. Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM–CHK2 Pathway

36. Longitudinal increase in albumin–bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis

38. Cell‐free and concentrated ascites reinfusion therapy versus large‐volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.

40. Rapid progression of colonic mucinous adenocarcinoma with immunosuppressive condition: A case report and review of literature

41. The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors

43. Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver

44. Usefulness of ultrasonography to assess the response to steroidal therapy for the rare case of type 2b immunoglobulin G4-related sclerosing cholangitis without pancreatitis: A case report

46. Efficacy and Safety of the Radiotherapy for Liver Cancer: Assessment of Local Controllability and Its Role in Multidisciplinary Therapy

48. Ten years' experience in Niigata Prefecture Liver Disease Consultation Center

49. Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma

Catalog

Books, media, physical & digital resources